Novo's weight-loss drug Wegovy cuts risk of heart disease by 20% - trial data

Norge Nyheter Nyheter

Novo's weight-loss drug Wegovy cuts risk of heart disease by 20% - trial data
Norge Siste Nytt,Norge Overskrifter
  • 📰 Reuters
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 97%

Novo Nordisk's obesity drug Wegovy has shown a clear medical benefit, reducing the risk of heart disease by 20% according to a large late-stage study. The positive results have boosted the Danish drugmaker's hopes of repositioning Wegovy as more than just a lifestyle drug.

A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File PhotoNovo shares hit record highssaid on Tuesday a large late-stage study showed its obesity drug Wegovy had a clear medical benefit, in addition to weight loss, boosting the Danish drugmaker's hopes of moving beyond Wegovy's image as a lifestyle drug.

The study called SELECT involved 17,500 patients aged 45 years or older with no prior history of diabetes and started almost five years ago testing if the weekly injection has medical benefits.up more than 10% to record highs. The shares have surged almost 150% over the past two years. Novo Nordisk said it expects to file for regulatory approvals of a label indication expansion for the weekly injection in the United States and European Union this year.Sydbank analyst Soren Lontoft Hansen said the better-than-expected results will cause a stir among doctors who prescribe anti-obesity drugs.

The increasingly popular drug has transformed the weight-loss market since its U.S. launch in June 2021, capturing the attention of patients, investors and celebrities worldwide and boosting Novo's shares.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

Reuters /  🏆 2. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Psychiatrists Prescribe Wegovy for Medication-Induced Weight GainPsychiatrists Prescribe Wegovy for Medication-Induced Weight GainPsychiatrists are increasingly prescribing the popular weight-loss drug Wegovy to patients who gain weight from medicines used to treat mental disorders, such as schizophrenia or bipolar disorder.
Les mer »

3 Reasons Why Shiba Inu (SHIB) Saw Massive 20% Breakthrough3 Reasons Why Shiba Inu (SHIB) Saw Massive 20% BreakthroughWith imminent launch of Shibarium, oversold market and investor confidence in face of scams, Shiba Inu (SHIB) saw significant 20% surge
Les mer »

Monthly costs for homebuyers rise nearly 20%Monthly costs for homebuyers rise nearly 20%The average rate on 30-year fixed mortgage rose to 6.9% this week.
Les mer »

The Top 20 Most-Followed Male K-Pop Idols On Instagram in 2023 | allkpopInstagram has become a go-to destination for K-Pop enthusiasts to stay updated on their favorite idols' day-to-day lives.K-pop idols use their perso…
Les mer »

Chicago weekend shootings: 6 dead, 20 hurtChicago weekend shootings: 6 dead, 20 hurtThe victims' ages range from 8 to 52.
Les mer »



Render Time: 2025-03-06 14:37:36